atishmundada

atishmundada's picture
ScienceStream
  • There are no activities to show.

User WAYS points

WAYS Points
0

Member Profile

Academic Level
PhD
Position
Counselor
Working Sector
Secondary School / College / University
Highest Degree
Ph. D.
Discipline
Life Sciences: Medicine
Reseach Topic
Transdermal drug delivery system
Publications

 A.S.Mundada, P.M.Satturwar, S.V.Fulzele, S.B.Joshi and A.K.Dorle “Characterization and Evaluation of Novel Film Forming Polymer for Drug Delivery” in Iranian Journal of Pharmaceutical Research (Accepted Manuscript) (Impact Factor-0.235).
 A.S.Mundada, J.G. Avari. “Evaluation of Gum Copal as rate controlling membrane for transdermal application: effect of plasticizers.” in Acta Pharmaceutica Sciencia, 2010. 52, 31-38 (Impact Factor-0.5).
 A.S.Mundada, J.G. Avari. “Flurbiprofen matrix type transdermal drug delivery system: in vitro evaluation” in Inventi Rapid: Pharm Tech, 2010, Vol. 1, Issue 1.
 A.S.Mundada, J.G. Avari. “Characterization and Evaluation of novel film former for sustained drug delivery” in Inventi Rapid: NDDS, 2010, Vol. 1, Issue 1.
 V.S.Borkar, H.H.Gangurde, V.S.Gulecha, P.K.Bhoyar, A.S.Mundada. Evaluation of in vitro anthelmintic activity of leaves of Butea monosperma in International Journal of Phytomedicine, 2010. 2, 31-35.
 A.S.Mundada, J.G. Avari. “Damar Batu as a Novel Matrix Former for the Transdermal Drug Delivery: in vitro evaluation” in Drug Development and Industrial Pharmacy, 2009. 35, 1147-1154 (Impact Factor-1.21).
 A.S.Mundada, J.G. Avari. “Permeability Studies of Damar Batu Free Films for Transdermal Application” in CI&CEQ, 2009. 15(2), 83-88.
 A.S.Mundada, B.K. Shrikhande. “Formulation and Evaluation of Ciprofloxacin Hydrochloride Soluble Ocular Drug Insert” in Current Eye Research, 2008. 33, 469-475 (Impact Factor-1.4).
 A.S.Mundada, B.K. Shrikhande. “Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride” in Drug Development and Industrial Pharmacy, 2006. 32, 443-448 (Impact Factor-1.21).
 A.S.Mundada, D.R. Meshram, H.B. Banbale, M.R. Bhalekar, J.G. Avari. “Formulation and Evaluation of Dispersible Taste Masked Tablet of Roxithromycin” in Asian Journal of Pharmaceutics, Apr. 2008, 116-119.
 A.S.Mundada, M.S. Mahajan, H.H. Gangurde, V.S. Borkar, V. S. Gulecha, R.A. Khandare. “Formulation and evaluation of polyherbal Antipsoriatic cream” in Pharmacologyonline, 2009. 2: 1185-1191.
 A.S.Mundada, B.K. Shrikhande. “Controlled release gel of Ciprofloxacin HCL for ophthalmic administration” in Indian Drugs, 2006. 43, 9-12.
 B.R.Gandhi, A.S.Mundada, P.P. Gandhi. “Chronopharmaceutics: as a clinically relevant drug delivery system” to Drug Delivery.(Manuscript accepted) (Impact Factor-1.5)
 H.H.Gangurde, A.S.Mundada, V.S.Gulecha, V.S.Borkar, M.S.Mahajan. “Gastroretentive Dosage form: an Overview” in Inventi Rapid: NDDS, 2010, Vol. 1, Issue 1.
 A.S.Mundada, J.G. Avari. “In situ gelling polymers in ocular drug delivery system: a review” in Critical Reviews in Therapeutic Drug Carrier Systems, 2009. 26, 85-118 (Impact Factor-3.99).
 C.S. Ramaa, A.R. Shirode, A.S. Mundada and V.J. Kadam. “Nutraceuticals- an emerging era in the treatment and prevention of cardiovascular diseases”, in Current Pharmaceutical Biotechnology, 2006. 7, 15-23 (Impact Factor-2.6).
 A.S.Mundada, Shilpa Jain, N.O. Chachada, J.G. Avari. “Taste masking approaches- a review: Part I”, in American pharmaceutical review, 2008. 11(4), 94-102.
 A.S.Mundada, Shilpa Jain, N.O. Chachada, J.G. Avari. “Taste masking approaches- a review: Part II”, in American pharmaceutical review, 2008. 11(6), 74-82.
 A.S.Mundada, N.V. Bhola, J.G. Avari. “Gastro retentive drug delivery systems-A technical note”, in Drug Delivery Technology, 2008. 8(7), 44-47.
 A.S.Mundada, J.G. Avari, S.P. Mehta, S.S. Pandit, A.T. Patil. “Recent advances in ophthalmic drug delivery system” in www.pharmainfo.net, Jan., 2008.
 A.S.Mundada, J.G. Avari, M.J. Bhattad, N.M. Nath, C.S. Ramaa. “Novel drug design for treatment of cancer: A new perspective”, in International Journal of Community Pharmacy, 2008. 1(2), 6-16.
 A.S.Mundada. “Nanoparticles: application in ophthalmic drug delivery systems”, in Pharma Times, 2006. 38(3), 13-17.
 A.S.Mundada, C.S. Ramaa, A.R. Shirode, V.J. Kadam. “Medical Representatives at the interface of health care system and pharmaceutical marketing - a study”, in IAPST Bulletin, Nov-Dec.2005. 2(2).
 A.S.Mundada, J.G. Avari. “Scenario of Indian pharmaceutical industries after GATT implementation”, in IAPST Bulletin, Jan-Feb.2006. 3(3).
 D.S. Khobragade, S.B. Bagade, A.S.Mundada, J.G. Avari. “Bioinformatics: Potential Applications in Pharmaceuticals”, in The Pharma Review, 2006. 4(22), 25-29.
 C.S. Ramaa, A.S.Mundada. “Old drugs, new impacts: Drug repositioning”, in Pharma Times, 2007. 39(7), 13-15.
 A.S.Mundada, N.V. Bhola, D.R. Meshram, J.G. Avari. “Taste masking approaches: a technical note”, in The Pharma Review, 2008.
 C.S. Ramaa, Rhea Mohan, A.S.Mundada, V.J. Kadam. “Retrometabolism based drug targeting-Soft drug approach”, in Indian Journal of Chemistry, 2008. 47B, 721-733.

Prizes / Awards

 Gold Medal from Govt. College of Pharmacy, Amravati for ranking first in the Final year B.Pharm.
 UGC Fellowship for postgraduate studies (M.Pharm.).
 Referee for the international journals AAPS Pharm. Sci. Tech., AAPS Journal, DDIP, Scientific Research and Essays and Asian Journal of Pharmaceutics.
 Name Included in Marquis Who's Who, 2009 edition.

Bio

I am research oriented individual.....

General and Contact Information

Title
Dr.
First Name
Atish
Last Name
Mundada
Date of Birth
09/05/1978
Country of Origin
India
Country of Residence
India
City
Nashik
Languages
Marathi, Hindi, English, Marwadi

History

Member for
2 years 31 weeks
Blog
View recent blog entries